Search Within

GME, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (228)
  2. Journal Article (177)
  3. Research Letter (10)
  4. Review (4)
  5. Correspondence (2)
  6. Editorial (2)
Groups
  1. Epidemiology and Biostatistics (423)
  2. Graduate Medical Education (423)
  3. Department of Medicine (399)
  4. Biostatistics Service (340)
  5. Hematology-Oncology Fellows (270)
  6. Hematologic Malignancies, Division of (256)

More Groups

People
  1. Gunjan Shah (95)
  2. Michael Scordo (94)
  3. Andriy Derkach (89)
  4. Sergio Giralt (85)
  5. Kylee Maclachlan (77)
  6. Alexander Lesokhin (71)

More People

Years
  1. 2025 (30)
  2. 2024 (105)
  3. 2023 (136)
  4. 2022 (95)
  5. 2021 (30)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (95)
  2. Blood (74)
  3. Clinical Lymphoma, Myeloma and Leukemia (27)
  4. Clinical Cancer Research (17)
  5. Annals of Oncology (12)
  6. Blood Advances (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. American Society of Hematology (86)
  3. Elsevier Inc. (54)
  4. Nature Publishing Group (38)
  5. American Association for Cancer Research (32)
  6. Oxford University Press (24)

More Publishers

Results (423)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma
    Meeting Abstract

    Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Individualized treatment-adjusted risk stratification in newly diagnosed multiple myeloma
    Meeting Abstract

    Maura, F.; Rajanna, A. R.; Derkach, A.; Ziccheddu, B.; Weinhold, N.; Maclachlan, K. H.; Diamond, B.; Davies, F. E.; Boyle, E.; Walker, B. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study
    Meeting Abstract

    Qualls, D.; Buege, M. J.; Dao, P.; Caimi, P. F.; Rutherford, S. C.; Wehmeyer, G.; Romancik, J. T.; Leslie, L. A.; Merrill, M. H.; Crombie, J. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Exocrine and endocrine pancreatic insufficiency induced by immune checkpoint inhibitors: A case-control study
    Meeting Abstract

    Satish, D.; Lin, I. H.; Flory, J.; Gerdes, H.; Faleck, D. M.
    American Journal of Gastroenterology (2022)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Technical feasibility of salvage endoscopic submucosal dissection after chemoradiation for locally advanced rectal adenocarcinoma
    Journal Article

    Leung, G.; Nishimura, M.; Hingorani, N.; Lin, I. H.; Weiser, M. R.; Garcia-Aguilar, J.; Pappou, E. P.; Paty, P. B.; Schattner, M. A.
    Gastrointestinal Endoscopy (2022)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save